Bio-Rad Labs Inc. A buy Citigroup Inc.
Start price
31.10.24
/
50%
€329.60
Target price
31.10.25
€413.33
Performance (%)
-16.99%
End price
01.11.25
€273.60
Summary
This prediction ended on 01.11.25 with a price of €273.60. The price of Bio-Rad Labs Inc. A has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -16.99%. Citigroup_Inc_ has a follow-up prediction for Bio-Rad Labs Inc. A where he still thinks Bio-Rad Labs Inc. A is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bio-Rad Labs Inc. A | -1.966% | -1.966% | -17.189% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Citigroup_Inc_ for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at Citigroup Inc. from $400.00 to $450.00. They now have a "buy" rating on the stock.
Ratings data for BIO provided by MarketBeat
In the thread Trading Bio-Rad Labs Inc. A
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€262.00
30.10.25
30.10.25
€322.88
30.10.26
30.10.26
1.45%
10.12.25
10.12.25
Stopped prediction by Citigroup_Inc_ for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€299.30
01.10.24
01.10.24
€361.20
01.10.25
01.10.25
-16.17%
02.10.25
02.10.25